James Engelhart
2018
In 2018, James Engelhart earned a total compensation of $3.2M as Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd., a 28% increase compared to previous year.
Compensation breakdown
| Bonus | $233,240 |
|---|---|
| Option Awards | $2,589,000 |
| Salary | $380,800 |
| Other | $14,028 |
| Total | $3,217,068 |
Engelhart received $2.6M in option awards, accounting for 80% of the total pay in 2018.
Engelhart also received $233.2K in bonus, $380.8K in salary and $14K in other compensation.
Rankings
In 2018, James Engelhart's compensation ranked 3,582nd out of 14,244 executives tracked by ExecPay. In other words, Engelhart earned more than 74.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,582 out of 14,244 | 75th |
Division Manufacturing | 1,320 out of 5,765 | 77th |
Major group Chemicals And Allied Products | 464 out of 2,128 | 78th |
Industry group Drugs | 383 out of 1,817 | 79th |
Industry Pharmaceutical Preparations | 295 out of 1,391 | 79th |
Source: SEC filing on April 11, 2019.
Engelhart's colleagues
We found four more compensation records of executives who worked with James Engelhart at Biohaven Pharmaceutical Holding Co Ltd. in 2018.
2018
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
2018
Charles Conway
Biohaven Pharmaceutical Holding Co Ltd.
Chief Scientific Officer
2018
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.
SVP, Clinical Operations
2018
John Tilton
Biohaven Pharmaceutical Holding Co Ltd.